Articles

Results 1 to 5 of 8
Most popular |Most recent


Institution Mandamus Review Limited to Colorable Constitution Claims

USA - March 30 2021 In Mylan Labs Ltd. v. Janssen Pharmaceutica N.V., the Federal Circuit reaffirmed it lacked jurisdiction over appeals from the PTAB denying IPR…

David M. Maiorana.

PTAB Holds Mock Oral Arguments for LEAP Attorneys

USA - August 19 2020 Holding its first mock oral arguments, the PTAB provided LEAP eligible participants with a unique opportunity to argue in front of PTAB judges. On…

Matthew W. Johnson, Stephanie M. Brooker.

American Rule Applied to PTAB Attorney’s Fees

USA - June 22 2020 In Amneal Pharmaceuticals LLC v. Almirall, LLC, the Federal Circuit recently found 35 U.S.C. § 285 did not authorize the Court awarding attorney’s…

Matthew W. Johnson.

Precedential: Declining To Use Discretion Under § 325(d) And § 314(a)

USA - April 10 2020 As we noted here, the PTAB recently designated two 35 U.S.C. § 325(d) cases precedential and one informative. Here is an in depth review of the…

Matthew W. Johnson.

Control of IPR Petition Remains Primary Factor in RPI Determination

USA - January 28 2020 Determining the Real Party-in-Interest (“RPI”) in an IPR can have critical implications for estoppel. A patent owner can prevent institution of an…

Matthew W. Johnson.